Ellen Snow - 16 Feb 2022 Form 4 Insider Report for Pear Therapeutics, Inc.

Role
Chief Accounting Officer
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Feb 2022
Net transactions value
$0
Form type
4
Filing time
18 Feb 2022, 15:45:40 UTC
Previous filing
07 Dec 2021
Next filing
18 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEARQ Restricted Stock Units Award $0 +61,576 $0.000000 61,576 16 Feb 2022 Common Stock 61,576 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
F2 The restricted stock units shall vest and settle as to 33% of the shares on January 14, 2023, 33% of the shares on January 14, 2024 and the final 34% on January 14, 2025.